Confirmation of TTTTA and TTTCA expansions in Families 1 (FAME3) and 5 (using exSTRa, STRetch and TRhist. a) Detection of outliers (individuals with likely expansions) of AAAAT (TTTTA, above) and AAATG (TTTCA, below) repeats at the FAME3 locus in three affected individuals and one healthy spouse sampled from Families 5 (FAME2) and 1 (FAME3) (total of 8 individuals tested) using exSTRa and STRetch. Individuals 1-III-16, 1-III-20 and 1-III-14 are detected as outliers (likely to have repeat expansions), whilst other individuals are not (including the FAME2 family). Affected individuals are indicated in red. b) Number of reads with TTTTA or TTTCA repeats detected by TRhist. The graphs show the number of reads for which AAAAT (TTTTA, left) or AAATG (TTTCA, right) instances represent between 75 and 151 nucleotides. As previously observed using ExpansionHunter, only the number of AAATG repeats is discriminative between control and FAME individuals. However, since TRhist analyzes the genome-wide distribution of repeats, an increased number of TTTCA repeats is detected for both FAME2 (Family 5, chr 2) and FAME3 (Family 2, chr 5). Supplementary Fig. 2 Pedigrees of FAME Families 5-13, tested negative for TTTTA/TTTCA expansion in MARCH6.
Families 5-7 have a TTTTA/TTTCA expansion on chr 2 (FAME2). Families 8-13 are also tested negative for FAME2. 22 Common haplotype highlighted in blue. Yellow region refers to the expansion locus. The core haplotype from these two families is located at chr5:10301295-10492095, and is 190.8 kb (0.35 cM) in size. It contains the whole of MARCH6, and two other genes. Supplementary Fig. 6 . Visualization of extracted nanopore reads covering the expansion. a) Dot plots comparing nanopore reads displaying the expansion (Y-axis, scale: 13 kb) with the corresponding hg19 reference region (X-axis, scale: 8.1 kb). The expansion appears as a vertical line. b) Analysis of raw nanopore reads using NanoSatellite. The signals corresponding to the expanded repeats appear in blue. , undefined (U) and pathogenic (P) alleles in the control individual (Ctrl) and the nine patients analyzed by molecular combing. P includes both likely pathogenic alleles (no red staining but Y ≥ 8.5) and definite pathogenic (with red staining) alleles. This graphs shows that for the individuals with the smallest expansions, the percentage of pathogenic alleles is lower than expected by chance, which suggests a higher overlap between normal and pathogenic alleles in these individuals. 
